This approach identified significant dependencies on key genes/proteins such as KRAS, NRAS, PABPC1, PPP2R1A, STAG2, and BRAF in thyroid cancer cell lines, underscoring their potential as critical therapeutic targets. The gene discussed is KRAS; the disease is thyroid gland carcinoma.